AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Block & Leviton LLP Reminds Shareholders of Important Deadlines: CTL, INGN, ZVO, ARA

May 3, 2019

BOSTON, May 03, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below, please contact Block & Leviton LLP at (888) 868-2385, by email at info@blockesq.com, or by visiting http://shareholder.law/.

CenturyLink, Inc. (NYSE: CTL) Lead Plaintiff Deadline: May 6, 2019Class Period: May 10, 2018 to March 4, 2019Learn more about this class action at: http://shareholder.law/centurylink

Inogen, Inc. (NASDAQ: INGN) Lead Plaintiff Deadline: May 6, 2019Class Period: November 8, 2017 to February 26, 2019Learn more about this class action at: http://shareholder.law/inogen

Bridgepoint Education Inc. (NASDAQ: ZVO) Lead Plaintiff Deadline: May 10, 2019Class Period: March 8, 2016 to March 7, 2019Learn more about this class action at: http://shareholder.law/bridgepoint

American Renal Associates Holdings, Inc. (NYSE: ARA) Lead Plaintiff Deadline: May 28, 2019Class Period: August 10, 2016 to March 27, 2019Learn more about this class action at: http://shareholder.law/ara

Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation’s largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:

BLOCK & LEVITON LLP 260 Franklin Street, Suite 1860 Boston, MA 02110(617) 398-5660 phone info@blockesq.com

SOURCE Block & Leviton LLP